The FDA has approved Impax Zomig (zolmitriptan) to treat migraines in patients aged 12 years and older. As the first nasal spray approved for this age group, the drug targets acute migraines with or without aura. Zomig was first approved for use in adults in 2003.
Thank you to our patients who volunteered for the clinical trials that helped get this drug approved.
FDA Approves ZOMIG® (zolmitriptan) Nasal Spray for Migraine in Pediatric Patients (Ages 12-17)
